2. Kento’s platform and associated technologies are designed to support remote monitoring, care coordination, and patient engagement. Features such as AI-driven insights and vitals tracking are intended for informational use only and do not replace professional clinical judgment. The system is not intended to diagnose, treat, cure, or prevent any disease and has not been reviewed or approved by the U.S. Food and Drug Administration.

3. The Kento platform is intended to support wellness and health education. It is not intended to diagnose, treat, cure, or prevent any disease. Features such as monitoring, coaching, and personalization are designed to assist healthcare professionals and patients but do not replace medical advice or clinical decision-making. Statements have not been evaluated by the U.S. Food and Drug Administration.

4. Statements reflect results from internal analyses and early findings from clinical partnerships. Outcomes such as cost reduction, satisfaction, or engagement are based on limited sample sizes and specific implementations. Results are not guaranteed and may vary. These statements have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

5. The Kento platform includes AI-powered tools designed to support clinician workflows. These features assist with monitoring, documentation, and recommendations, but do not replace clinical judgment. Final decisions regarding diagnosis and treatment remain the responsibility of qualified healthcare professionals. The platform is not intended to diagnose, treat, cure, or prevent any disease and has not been evaluated by the U.S. Food and Drug Administration.

6. Figures presented are based on internal analyses, customer-reported outcomes, and early clinical partnerships, including pilot data from U.S. health systems. Results such as reduction in hospitalizations, billable session increases, and operational efficiencies reflect averages or maximum observed improvements in controlled settings and may not be generalizable. These statements have not been reviewed or approved by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

7. Performance metrics reflect internal estimates and early pilot data from U.S. healthcare partners. ROI and billing increases are based on specific clinical deployments and may vary depending on implementation, population, and reimbursement structures. These results are not guaranteed and have not been reviewed or approved by the U.S. Food and Drug Administration. The Kento platform is not intended to diagnose, treat, cure, or prevent any disease.